Figure 1From: Detection of circulating tumor cells in blood of metastatic breast cancer patients using a combination of cytokeratin and EpCAM antibodies Kaplan-Meier plot estimating overall survival for 3 risk groups (0 CTC, 1–4 CTC, ≥5 CTC). Back to article page